ARCHIVES

ODAC To Advise FDA on First Biosimilars Application Jan. 7

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001

In Brief: NCI’s Cutler Clarifies Policy On Release Of Survey Data, Tape Duplicates Will Be Available At Cost

September 6, 1974

Tempero, Johnson To Lead ASCO

March 28, 2003

In Brief: Gaus Heads AHCPR; Lineberger Names New Leadership In Oncology and Clinical Research

July 22, 1994

Gallo’s Deputy Removed Pending Investigation

January 11, 1991

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013